PTC Therapeutics, Inc.
PTCT
$73.46
-$1.56-2.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.81M | -134.97M | 15.90M | -64.85M | 866.56M |
| Total Depreciation and Amortization | 15.41M | 12.90M | 11.11M | 7.58M | 7.22M |
| Total Amortization of Deferred Charges | 305.00K | 313.00K | 305.00K | 302.00K | 299.00K |
| Total Other Non-Cash Items | 38.75M | -3.64M | -8.74M | 15.35M | 38.10M |
| Change in Net Operating Assets | -110.70M | 91.11M | -84.88M | -16.72M | -42.08M |
| Cash from Operations | -59.04M | -34.27M | -66.30M | -58.33M | 870.10M |
| Capital Expenditure | -1.20M | -2.37M | -3.45M | -1.32M | -1.72M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 70.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.54M | 36.38M | -286.18M | -420.69M | -182.71M |
| Cash from Investing | -93.74M | 34.01M | -289.62M | -422.01M | -184.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -1.61M | -- | -- |
| Issuance of Common Stock | 6.40M | 62.50M | 16.83M | 3.96M | 15.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 240.00M | 0.00 | 0.00 | -6.34M |
| Cash from Financing | 6.40M | 302.50M | 15.22M | 3.96M | 9.41M |
| Foreign Exchange rate Adjustments | -1.52M | 9.80M | -6.06M | 13.59M | 5.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.90M | 312.03M | -346.77M | -462.79M | 700.55M |